China Metformin HCL Prices Rise 11.7% M-o-M on Export Demand and Tight Supply Conditions

China Metformin HCL Prices Rise 11.7% M-o-M on Export Demand and Tight Supply Conditions

Phoebe Cary 27-Apr-2026

Metformin HCL in China rose sharply in March as export activity and tighter prompt availability supported demand. Early momentum reflected high throughput from API producers, while mid-month inspections prompted output curtailments at smaller facilities. Overseas formulators accelerated purchases ahead of anticipated second-quarter tender resets, compressing immediate availability and drawing down Shanghai prompt stocks. Tighter Customs checks extended clearance windows, narrowing free-on-board availability and reinforcing upward momentum across Shanghai listings. Demand flows favored finished-dose manufacturers and formulators, with Indian and Brazilian buyers front-loading to secure raw material ahead of tenders. Export activity and steady domestic hospital procurement underpinned the market. Indian finished-dose manufacturers lifted API intake by about nine percent month on month, while hospital dispensing in China rose around four percent. Market response included firm demand from diabetes medicine channels despite higher feedstock costs. Integrated producers maintained above-baseline operating rates and leveraged captive dimethylamine lines, but methanol-related feedstock risk remained. Near-term outlook suggests continued upside into April and May.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.